glp-1 testosterone weight loss drugs may boost testosterone, improve erectile dysfunction GLP-1s: Myth Vs. Fact https://theonion.com/glp-1s-myth-vs-fact

Statistical analysis Events of reported pancreatitis and exposure (patient years) to either incretin-based drugs (GLP-1 receptor agonists or DPP-4 inhibitors) or non-incretin-based comparator drugs/placebo were compared using contingency table analysis, calculating the ORs, 95% CIs and p values for the comparison, using GraphPad Prism version 5.02 for Windows (GraphPad Software, San Diego, CA, USA

Most Medicare patients receive significant coverage for MDWatchs programs and services, including chronic condition management, health coaching, and virtual consultations

The starting dose of retatrutide and optimal dose selection will likely be refined further when FDA labeling is finalized

Falls are a leading cause of disability and death after age 65